Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects

Diabetologia

Volumn 46, Issue 4, 2003, Pages 538-545

  Chang, T I ^a   Horal, M ^a   Jain, S K ^b   Wang, F ^a   Patel, R ^a   Loeken, M R ^a  

^a JOSLIN DIABETES CENTER   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Cell death; Diabetic pregnancy; Embryogenesis; Free radicals; Gene expression; Neural tube defects; Oxidative stress; Pax 3

Indexed keywords

ALPHA TOCOPHEROL; ANTIMYCIN A1; DNA FRAGMENT; GENE PRODUCT; GLUCOSE; GLUTATHIONE ETHYL ESTER; TRANSCRIPTION FACTOR PAX3; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DIABETES MELLITUS; ELECTROPHORESIS; EMBRYO; EMBRYO DEVELOPMENT; EMBRYONAL CARCINOMA; FEMALE; GENE EXPRESSION REGULATION; HYPERGLYCEMIA; MATERNAL DIABETES MELLITUS; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; OXIDATIVE STRESS; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0037955858     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-003-1063-2     Document Type: Article

References (62)

1. Martinez-Frias ML (1994) Epidemiological analysis of outcomes of pregnancy in diabetic mothers: identification of the most characteristic and most frequent congenital anomalies. Am J Med Genet 51:108-113
2. Kucera J (1971) Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med 7:61-70
3. Mills JL, Baker L, Goldman AS (1979) Malformations in infants of diabetic mothers occur before the seventh gestational week: Implications for treatment. Diabetes 28:292-293
4. Cousins L (1983) Congenital anomalies among infants of diabetic mothers: etiology, prevention, prenatal diagnosis. Am J Obstet Gynecol 147:333-338
5. Becerra JE, Khoury MJ, Cordero JF, Erickson JD (1990) Diabetes mellitus during pregnancy and the risks for the specific birth defects: a population-based case-control study. Pediatrics 85:1-9
6. Miodovnik M, Mimouni F, Tsang RC, Ammar E, Kaplan L, Siddiqi TA (1986) Glycemic control and spontaneous abortion in insulin-dependent diabetic women. Obstet Gynecol 68:366-369
7. Kitzmiller JL, Cloherty JP, Younger MD et al. (1978) Diabetic pregnancy and perinatal morbidity. Am J Obstet Gynecol 131:560-580
8. Mills JL (1982) Malformations in infants of diabetic mothers. Teratology 25:385-394
9. Langer O, Conway DL (2000) Level of glycemia and perinatal outcome in pregestational diabetes. J Matern Fetal Med 9:35-41
10. Suhonen L, Hiilesmaa V, Teramo K (2000) Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus. Diabetologia 43:79-82
11. Schaefer-Graf UM, Buchanan TA, Xiang A, Songster G, Montoro M, Kjos SL (2000) Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol 182:313-320
12. Aberg A, Westbom L, Kallen B (2001) Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev 61:85-95
13. Trocino RA, Akazawa S, Ishibashi M et al. (1995) Significance of glutathione depletion and oxidative stress in early embryogenesis in glucose-induced rat embryo culture. Diabetes 44:992-998
14. 2 levels in rat embryos exposed to a diabetic environment. Diabetes 48:813-820
15. Yang X, Borg LA, Eriksson UJ (1997) Altered metabolism and superoxide generation in neural tissue of rat embryos exposed to high glucose. Am J Physiol 272:E173-E180
16. el-Hage S, Singh SM (1990) Temporal expression of genes encoding free radical-metabolizing enzymes is associated with higher mRNA levels during in utero development in mice. Dev Genet 11:149-159
17. Hagay ZJ, Weiss Y, Zusman I et al. (1995) Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. Am J Obstet Gynecol 173:1036-1041
18. Wentzel P, Eriksson UJ (1998) Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro. Diabetes 47:677-684
19. Siman CM, Eriksson UJ (1997) Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes 46:1054-1061
20. Siman CM, Eriksson UJ (1997) Vitamin C supplementation of the maternal diet reduces the rate of malformation in the offspring of diabetic rats. Diabetologia 40:1416-1424
21. Sivan E, Reece EA, Wu Y-K, Homko CJ, Polansky M, Borenstein M (1996) Dietary vitamin E prophylaxis and diabetic embryopathy: morphologic and biochemical analysis. Am J Obstet Gynecol 175:793-799
22. Eriksson U, Siman CM (1996) Pregnant diabetic rats fed the antioxidant butylated hydroxytoluene show decreased occurrence of malformations in offspring. Diabetes 45:1497-1502
23. Viana M, Herrera E, Bonet B (1996) Terotogenic effects of diabetes mellitus in the rat. Prevention by vitamin E. Diabetologia 39:1041-1046
24. Phelan SA, Ito M, Loeken MR (1997) Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes 46:1189-1197
25. Fine E, Horal M, Chang T, Fortin G, Loeken M (1999) Hyperglycemia is responsible for altered gene expression, apoptosis, and neural tube defects associated with diabetic pregnancy. Diabetes 48:2454-2462
26. Auerbach R (1954) Analysis of the developmental effects of a lethal mutation in the house mouse. J Exp Zool 127:305-329
27. Loffredo CA, Wilson PD, Ferencz C (2001) Maternal diabetes: an independent risk factor for major cardiovascular malformations with increased mortality of affected infants. Teratology 64:98-106
28. Conway SJ, Henderson DJ, Copp AJ (1997) Pax3 is required for cardic neural crest migration in the mouse: evidence from the splotch (Sp2H) mutant. Development 124:505-514
29. Epstein JA, Li J, Lang D et al. (2000) Migration of cardiac neural crest cells in Splotch embryos. Development 127:1869-1878
30. Nemoto S, Takeda K, Yu ZX, Ferrans VJ, Finkel T (2000) Role for mitochondrial oxidants as regulators of cellular metabolism. Mol Cell Biol 20:7311-7318
31. Sullivan DM, Wehr NB, Fergusson MM, Levine RL, Finkel T (2000) Identification of oxidant-sensitive proteins: TNF-alpha induces protein glutathiolation. Biochemistry 39:11121-11128
32. Corwin LM, Humphrey LP (1972) Vitamin E: substrate-dependent growth effect on cells in culture. Proc Soc Exp Biol Med 141:609-612
33. McBurney MW, Jones-Villeneuve EMV, Edwards MKS, Rudnicki M (1983) Controlled development of embryonic tissues in a differentiating embryonal carcinoma cell line. In: Silver LM, Strickland S (eds) Teratocarcinoma stem cells, vol 10. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp 121-124
34. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501
35. Jain SK, McVie R, Duett J, Herbst JJ (1989) Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 38:1539-1543
36. Turrens JF, Alexandre A, Lehninger AL (1985) Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem Biophys 237:408-414
37. Garcia-Ruiz C, Colell A, Morales A, Kaplowitz N, Fernandez-Checa JC (1995) Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes. Mol Pharmacol 48:825-834
38. Pruitt SC (1992) Expression of Pax-3 and neuroectoderm-inducing activities during differentiation of P19 embryonal carcinoma cells. Development 116:573-583
39. Evans HM, Bishop KS (1923) The production of sterility with nutritional regimes adequate for growth and its cure with other foodstuffs. J Metab Res 3:233-316
40. Sure B (1923) Dietary requirements for reproduction. II. The existence of a specific vitamin for reproduction. J Biol Chem 58:693-709
41. Verma K, King DW (1967) Disorders of the developing nervous system of vitamin E-deficient rats. Acta Anat 67:623-635
42. 14]glucose by postimplantation mouse embryos in vitro. J Embryol Exp Morphol 74:133-142
43. Neubert D (1971) Aerobic glycolysis in mammalian embryos. In: Bass R, Beck F, Merker HJ, Neubert D, Randhahn B (eds) Metabolic pathways in mammalian embryos during organogenesis and its modification by drugs. Freie Universitat Berlin, pp 225-248
44. Scott W Jr (1977) Cell death and reduced proliferative rate. In: Wilson J, Fraser F (eds) Handbook of teratology, vol 2. Plenum Press, New York, pp 81-98
45. Sulik KK, Cook CS, Webster WS (1988) Teratogens and craniofacial malformations: relationships to cell death. Development 103 (Suppl.):213-232
46. Savitsky PA, Finkel T (2002) Redox regulation of Cdc25C. J Biol Chem 277:20535-20540
47. Jayaraman L, Murthy KG, Zhu C, Curran T, Xanthoudakis S, Prives C (1997) Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev 11:558-570
48. Kambe F, Nomure Y, Okamot T, Seo H (1996) Redox regulation of thyroid-transcription factors, Pax-8 and TTF-1, is involved in their increased DNA-binding activities by thyrotropin in rat thyroids FRTL-5 cells. Mol Endocrinol 10:801-812
49. Pani L, Horal M, Loeken MR (2002) Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3-dependent development and tumorigenesis. Genes Dev 16:676-680
50. Akazawa S, Unterman T, Metzger BE (1994) Glucose metabolism in separated embryos and investing membranes during organogenesis in the rat. Metabolism 43:830-835
51. Lotem J, Peled-Kamar M, Groner Y, Sachs L (1996) Cellular oxidative stress and the control of apoptosis by wildtype p53, cytotoxic compounds, and cytokines. Proc Natl Acad Sci USA 93:9166-9171
52. Xu D, Finkel T (2002) A role for mitochondria as potential regulators of cellular life span. Biochem Biophys Res Commun 294:245-248
53. Xu D, Neville R, Finkel T (2000) Homocysteine accelerates endothelial cell senescence. FEBS Lett 470:20-24
54. Nakano E, Higgins JA, Powers HJ (2001) Folate protects against oxidative modification of human LDL. Br J Nutr 86:637-639
55. Chern CL, Huang RF, Chen YH, Cheng JT, Liu TZ (2001) Folate deficiency-induced oxidative stress and apoptosis are mediated via homocysteine-dependent overproduction of hydrogen peroxide and enhanced activation of NF-kappaB in human Hep G2 cells. Biomed Pharmacother 55:434-442
56. Parman T, Wiley MJ, Wells PG (1999) Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity. Nat Med 5:582-585
57. Wells PG, Winn LM (1996) Biochemical toxicology of chemical teratogenesis. Crit Rev Biochem Mol Biol 31:1-40
58. Hassoun EA, Walter AC, Alsharif NZ, Stohs SJ (1997) Modulation of TCDD-induced fetotoxicity and oxidative stress in embryonic and placental tissues of C57BL/6J mice by vitamin E succinate and ellagic acid. Toxicology 124:27-37
59. Bankson DD, Kestin M, Rifai N (1993) Role of free radicals in cancer and atherosclerosis. Clin Lab 13:463-480
60. Graf WD, Oleinik OE, Pippenger CE, Eder DN, Glauser TA, Shurtleff DB (1995) Comparison of erythrocyte anti-oxidant enzyme activities and embryologic level of neural tube defects. Eur J Pediatr Surg 5 [Suppl 1]:8-11
61. Werler MW, Louik C, Shapiro S, Mitchell AA (1996) Prepregnant weight in relation to risk of neural tube defects. JAMA 275:1089-1092
62. Shaw GM, Velie EM, Schaffer D (1996) Risk of neural tube defect-affected pregnancies among obese women. JAMA 275:1093-1096